Cardura vs. Clopidogrel: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Cardura and Clopidogrel. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 146,816 people who take Cardura and Clopidogrel, and is updated regularly.
What is Cardura?
Cardura has active ingredients of doxazosin mesylate. It is often used in high blood pressure. eHealthMe is studying from 20,379 Cardura users. Check the latest studies of Cardura.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.
146,816 people who take Cardura and Clopidogrel are studied.
Drugs being compared in this study:
- Clopidogrel (clopidogrel)
- Cardura (doxazosin mesylate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Cardura:
- not at all: 2.96 %
- somewhat: 20.72 %
- moderate: 41.59 %
- high: 29.6 %
- very high: 5.14 %
Clopidogrel:
- not at all: 3.03 %
- somewhat: 14.96 %
- moderate: 30.08 %
- high: 42.52 %
- very high: 9.41 %
Want to compare Cardura with Clopidogrel?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Cardura (20,024 reports)
- Clopidogrel (91,050 reports)
Browse all side effects of Cardura:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on doxazosin mesylate and clopidogrel (the active ingredients of Cardura and Clopidogrel, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Latanoprost and Phenytoin - 32 seconds ago
- Drug interactions of Levetiracetam and Memantine Hydrochloride - 45 seconds ago
- Could Rinvoq cause Suicidal Ideation? - 55 seconds ago
- Drug interactions of Sumatriptan and Niaspan - a minute ago
- Could Keppra cause Atrial Fibrillation/Flutter? - a minute ago
- Drug interactions of Fludarabine Phosphate and Methotrexate Sodium - a minute ago
- Could Vitamin B cause Photophobia? - a minute ago
- Could Moxifloxacin Hydrochloride cause Weakness? - a minute ago
- Could Calcium cause Knee Joint Replacement? - a minute ago
- Could Telmisartan cause Agitation Aggravated? - a minute ago